Anti-infective medical device
    1.
    发明授权
    Anti-infective medical device 有权
    抗感染医疗器械

    公开(公告)号:US08691258B2

    公开(公告)日:2014-04-08

    申请号:US11008445

    申请日:2004-12-09

    IPC分类号: A61F13/00 A01N25/00

    CPC分类号: A61N1/05 A61N1/0568 A61N1/375

    摘要: Implantable medical devices (IMDS) having anti-infective properties are described. Anti-infective agents are disposed in, on, or about at least a portion of a surface of the medical device. The anti-infective agents are disposed in or on a vehicle, which may be in the form of a coating layer or covering. The vehicle may be biodegradable so that, over time, the anti-infective agent is removed from a tissue location into which the device is implanted, reducing the likelihood that microorganisms resistant to the anti-infective agent will develop. IMDs having an anti-infective agent and an anti-activity agent disposed therein, thereabout, or thereon are also described. The anti-activity agent interferes with the activity of the anti-infective agent, may be released from a surface at the IMD at a time when activity of the anti-infective agent is no longer desired, and may reduce the likelihood that microorganisms resistant to the anti-infective agent will develop.

    摘要翻译: 描述具有抗感染性的植入式医疗装置(IMDS)。 抗感染剂设置在医疗装置的表面的至少一部分上,其上或附近。 抗感染剂设置在车辆中或车辆上,其可以是涂层或覆盖物的形式。 载体可以是可生物降解的,使得随着时间的推移,抗感染剂从植入装置所在的组织位置移除,降低了抗感染剂抗微生物的可能性。 还描述了其上设置有抗感染剂和抗活性剂的IMD,其上或其上。 干扰抗感染剂的活性的抗活性剂可以在不再需要抗感染剂的活性的时候从IMD的表面释放,并且可能降低抗微生物抗性的可能性 抗感染剂会发展。

    MINOCYCLINE AND RIFAMPIN MICROPARTICLES
    7.
    发明申请
    MINOCYCLINE AND RIFAMPIN MICROPARTICLES 审中-公开
    MINOCYCLINE和RIFAMPIN MICROPARTICLES

    公开(公告)号:US20110269720A1

    公开(公告)日:2011-11-03

    申请号:US12768913

    申请日:2010-04-28

    IPC分类号: A61K31/65 A61P31/04

    摘要: Methods and kits for treating infection associated with implantation of a medical device use of minocycline and rifampin microparticles. The microparticles, in a suitable medium, can be injected in a patient in proximity to the device. The drugs may be configured to be released from the polymer matrix in a controlled manner by manipulation of the properties of the polymer forming the microparticle. By injecting the drugs in the form of microparticles, the drugs can be distributed in a manner so that the entire pocket is protected without affecting device function. The microparticles can be produced aseptically without affecting the manufacturing of the device.

    摘要翻译: 用于治疗与植入医疗器械相关的感染的方法和试剂盒使用米诺环素和利福平微粒。 在合适的介质中的微粒可以被注射到设备附近的患者体内。 药物可以被配置为通过操纵形成微粒的聚合物的性质以受控的方式从聚合物基质释放。 通过以微粒的形式注射药物,药物可以以使得整个口袋被保护而不影响装置功能的方式分布。 微粒可以无菌地生产,而不影响器件的制造。

    Benzodiazepine formulation in a polyorthoester carrier
    10.
    发明授权
    Benzodiazepine formulation in a polyorthoester carrier 有权
    苯并二氮类制剂在聚原酸酯载体中

    公开(公告)号:US08940315B2

    公开(公告)日:2015-01-27

    申请号:US12426031

    申请日:2009-04-17

    摘要: Effective treatments of pain for extended periods of time are provided. The treatments include the administration of one or more drug depots intraspinally wherein the drug depots include an effective amount of a benzodiazepine, such as midazolam, formulated within a polyorthoester. By administration of one or more drug depots, one can relieve pain caused by diverse sources, including but not limited to chronic pelvic pain syndromes, spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discongenic back pain and joint pain, as well as pain that is incidental to surgery. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days or at least one hundred and thirty-five days.

    摘要翻译: 提供长时间有效的疼痛治疗。 治疗方法包括给药一种或多种药物贮库,其中药物贮库包括配制在聚原酸酯内的有效量的苯二氮卓类,如咪达唑仑。 通过管理一个或多个药物库,可以减轻由多种来源引起的疼痛,包括但不限于慢性盆腔疼痛综合征,椎间盘突出症(即坐骨神经痛),脊椎脱位,狭窄,恶性背痛和关节疼痛,以及 手术附带的疼痛。 在一些实施方案中,缓解可以是至少二十五天,至少五十天,至少一百天或至少一百三十五天。